Association of Inflammatory Metabolic Markers in Psoriasis Patient: A Case-Control Study in Karbala City
1
Basic Sciences, College of Dentistry, University of Al-Ameed, Karbala, Iraq
2
Al-Zahraa University for Women, Collage of Health and Medical Technologies Faculty, Department of Radiologic Technology.
Received: 2025-11-11
Revised: 2025-12-09
Accepted: 2025-12-26
Published: 2026-01-01
B This case-control study was investigated the systemic inflammatory markers in 70 patients with psoriasis against 30 healthy controls in Karbala teaching hospitals, Iraq. Demographic, hematological and immunological parameters were assessed, neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), interleukin (IL)-17, IL-23 and C-reactive protein (CRP). The patients with psoriasis had a high inflammatory marker that were significantly high in comparison to the controls: SII (632.78 vs 377.2, p=0.032), SIRI (1.042 vs 0.833, p=0.041), and CRP (6.4 mg/L vs 3.8 mg/L, p=0.01). The amount of vitamin B12 was significantly reduced among patients (138.5 pg/mL vs 391.5 pg/mL, p<0.001). A significant correlation was found between SII and CRP (r=0.714, p=0.043) and between SII and IL-23 (r=0.471, p=0.007), and IL-17 demonstrated weaker correlations (SII: r=0.136, p=0.154), The results suggest that SII/SIRI is useful as a biomarker in the context of resource limitations and indicate the existence of possible metabolic comorbidities in the population. The clinical implication of the deficiency of vitamin B12 and IL-23/IL-17 imbalance in Middle East psoriasis patients should be investigated in further studies